The future of obesity treatment

Friday 3 February 2012

Venue: The Royal College of Physicians, 11 St. Andrews Place, LONDON, NW1 4LE

Obesity and its consequences are set to become one of the most important health care issues of the next few decades. Neither public health policy nor the available medical treatments have been able to consistently address the obesity epidemic, which continues to affect patients' health, quality of life and the wider impact on society. We believe that the challenge needs to be addressed through a multidisciplinary approach involving and promoting collaboration across different specialities including physicians, surgeons, policy makers, commissioners and managers.

London 2012: The Future of Obesity Treatment aims to review the current status of obesity treatment and to discuss how best to address the challenges in the future. We are privileged to have the world's leading authorities to address this challenging topic and we
aim to make the meeting as interactive as possible with expert panel discussions and a final debate on the different treatment options.

The meeting is open to general practitioners, surgeons, physicians, dialectologists, endocrinologists, gastroenterologists, endoscopists, commissioners and managers, all of whom face their own specific challenges in this evolving field. Our invitation is also extended to trainees and allied health care professionals involved in the specialist management of patients suffering from obesity.

We are delighted to invite you to attend this state of the art International Symposium on February 3rd 2012 at the Royal College of Physicians in London.

Delegate fees:

Early bird rates:
RSM Consultant/GP £100
RSM Trainee/AHP £80
Consultant/GP £120
Trainee/AHP £90

CPD: Applied for

Download a booking form
Download a map



8.30 am

Coffee/Registration

9.30 am

Welcome address and introduction
Mr Gianluca Bonanomi, Chelsea and Westminster Hospital London

9.40 am

How will the international diabetes federation statement change the future?
Prof Sir George Alberti, University of Newcastle/Imperial College London

Morning Session: The medical approach to obesity
Chair: James Ahlquist (Royal Society of Medicine)
Michael Feher (Chelsea and Westminster)

10.00 am

Obesity: What is the challenge for the community?
Dr David Haslam, Chairman, National Obesity Clinic

10.20 am

Which patients stand to gain the most from obesity treatment?
Dr Simon Aylwin, King's College London

10.40 am

What is the current status of obesity and diabetes treatment?
Prof john wilding, University of London

11.00 am

How can health care systems afford obesity and diabetes treatment?
Mr Mike Lander, Commissioner South east Coast England

11.20 am

Coffee

Morning Session: Novel therapeutic approaches to obesity
Chair: Bobby Prasad (Chelsea and Westminster) Kevin Shotliff (Chelsea and Westminster)

11.40 am

Is the magic medicine on the horizon?
Prof Steve Bloom, Imperial College London

12.00 pm

Can obesity be treated using an endoscope?
Dr Christopher Thompson, Harvard Medical School, Boston, USA

12.20 pm

Panel discussion

12.50 pm

Lunch

Afternoon Session: The surgical approach to obesity
Chair: Ahmed R. Ahmed (Imperial)
Evangelos Efthimiou (Chelsea and Westminster)

1.50 pm

The future of obesity treatment: how can we influence policy makers?
Mr Michael Parker, Royal College of Surgeons

2.00 pm

What are the long term outcomes of bariatric surgery? The good, the bad and the ugly.
Dr Nicholas Christou, McGill University, Montreal, Canada

2.20 pm

What clinical evidence do we need to move bariatric and metabolic surgery forward?
Dr Philip R Schauer, Cleveland Clinic, USA

2.40 pm

What does basic science today predict for future obesity treatments?
Dr Carel le Roux, Imperial college London

2.55 pm

Panel discussion

3.20 pm

Coffee

Debate: Obesity is the question: What will be the answer - a tablet, an endoscope or a scalpel?
Chair: Gianluca Bonanomi (Chelsea and Westminster)
Carel le Roux (Imperial)

3.40 pm

Medical motion:
Prof Nicholas Finer, University College London

Endoluminal motion:
Dr Christopher Thompson, Harvard Medical School, Boston, USA

Surgical motion:
Mr Alberic Fiennes, President, British Obesity and Metabolic Surgery Society

4.40 pm

Recommendations and closing remarks

Meeting ref: EDC05

CPD (Applied for)


More about this section

Contact:
Tel: +44 (0) 20 7290 3937
Fax: +44 (0) 20 7290 2989
Email: Coordinator

Events Co-ordinator:
Lydia Gillam
Tel: +44 (0) 20 7290 3937
Fax: +44 (0) 20 7290 2989